# Corridor Pharmaceuticals, Inc.: Form D filings

Corridor Pharmaceuticals, Inc., a biotechnology company in Baltimore, MD, filed 3 Form D notices with the SEC between 2009 and 2013. The latest, on January 31, 2013, reports $1.6 million sold of a $1.8 million offering to 9 investors.

Find out what Corridor Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Corridor%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Corridor%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcorridor-pharmaceuticals-inc-1471665)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Corridor%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Corridor%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcorridor-pharmaceuticals-inc-1471665)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1122 Kenilworth Drive, Suite 401, Baltimore, MD, 21204
- Phone: (410) 616-0916
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1471665

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 31, 2013 | New notice | $1,800,000 | $1,558,429 | $241,571 | 9 | Jan 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1471665/000147166513000003/0001471665-13-000003-index.htm) |
| Jun 24, 2010 | New notice | $14,475,000 | $13,012,475 | $1,462,525 | 8 | Jun 11, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1471665/000147166510000002/0001471665-10-000002-index.htm) |
| Sep 10, 2009 | New notice | $17,502,000 | $4,161,000 | $13,341,000 | 8 | Aug 28, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1471665/000147166509000001/0001471665-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Leonard Patrick Gage | Director |  |
| Peter Patrick Greenleaf | Director |  |
| David Patrick King | Director |  |
| Brian Patrick Halak | Director |  |
| Anne Patrick Shiflett | Executive Officer |  |
| Mark Strobeck | Executive Officer, Director |  |

## Other biotechnology companies in Maryland that filed recently

- [BlueHealer Inc.](https://specstream.ai/data/form-d/company/bluehealer-inc-2162934) $1 · Nov 4, 2026
- [Accufy Diagnostics, Inc.](https://specstream.ai/data/form-d/company/accufy-diagnostics-inc-2089723) $2 million · Oct 28, 2026
- [OS Therapies Inc](https://specstream.ai/data/form-d/company/os-therapies-inc-1795091) $7.2 million · Oct 23, 2026
- [Kaigene, Inc.](https://specstream.ai/data/form-d/company/kaigene-inc-1919055) $55 million · Oct 14, 2026
- [Templar Nova, Inc.](https://specstream.ai/data/form-d/company/templar-nova-inc-2158642) $7 million · Oct 7, 2026
- [Monocacy Therapeutics Inc.](https://specstream.ai/data/form-d/company/monocacy-therapeutics-inc-2137361) $25,000 · Oct 7, 2026
- [Seraxis Holdings, Inc.](https://specstream.ai/data/form-d/company/seraxis-holdings-inc-1845486) $10 million · Sep 24, 2026
- [Uvantis Therapeutics, Inc.](https://specstream.ai/data/form-d/company/uvantis-therapeutics-inc-2156954) $100,000 · Sep 23, 2026
- [Gliknik Inc](https://specstream.ai/data/form-d/company/gliknik-inc-1411569) $15 million · Sep 17, 2026
- [Georgiamune, Inc.](https://specstream.ai/data/form-d/company/georgiamune-inc-2148230) $92.7 million · Aug 17, 2026

[Every Form D from the week of Jan 28, 2013](https://specstream.ai/data/form-d/week/2013-01-28) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Corridor Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).